Vaxart Files 8-K: Voting, Reg FD, Financials

TL;DR

Vaxart dropped an 8-K covering shareholder votes, Reg FD, and financials. Check it out.

AI Summary

Vaxart, Inc. filed an 8-K on September 8, 2025, reporting on matters submitted to a vote of security holders, Regulation FD disclosures, and financial statements and exhibits. The filing date is September 8, 2025, with the earliest event reported on September 5, 2025. The company is incorporated in Delaware and its principal business address is 170 Harbor Way, Suite 300, South San Francisco, CA 94080.

Why It Matters

This 8-K filing provides updates on key corporate governance and financial matters for Vaxart, Inc., which could impact investor understanding of the company's operations and compliance.

Risk Assessment

Risk Level: low — This filing is a routine 8-K reporting on standard corporate events and disclosures, not indicating any immediate material adverse changes.

Key Players & Entities

• Vaxart, Inc. (company) — Registrant
• September 5, 2025 (date) — Earliest event reported
• September 8, 2025 (date) — Filing date
• Delaware (jurisdiction) — State of incorporation
• 170 Harbor Way, Suite 300, South San Francisco, CA 94080 (address) — Business address

FAQ

Key Financial Figures

• $0.0001 — nge on which registered Common Stock , $0.0001 par value VXRT The Nasdaq Capital M

Filing Documents

• vxrt20250908_8k.htm (8-K) — 34KB
• ex_859833.htm (EX-99.1) — 14KB
• 0001437749-25-028570.txt ( ) — 182KB
• vxrt-20250905.xsd (EX-101.SCH) — 3KB
• vxrt-20250905_def.xml (EX-101.DEF) — 11KB
• vxrt-20250905_lab.xml (EX-101.LAB) — 15KB
• vxrt-20250905_pre.xml (EX-101.PRE) — 11KB
• vxrt20250908_8k_htm.xml (XML) — 3KB

07

Item 5.07 Submission of Matters to a Vote of Security Holders. On September 5, 2025, Vaxart, Inc. (the "Company") convened the Company's special meeting of stockholders (the "Special Meeting"). Proxies had been submitted by stockholders representing approximately 64.25% of the shares of the Company's common stock outstanding and entitled to vote, which constituted a quorum. The proposal listed in the proxy statement (the "Proxy Statement") filed with the U.S. Securities and Exchange Commission (the "SEC") on August 6, 2025, for the Special Meeting was not voted on at the Special Meeting because the Company's board of directors (the "Board of Directors") believes that it is important to provide stockholders additional time within which to vote, and therefore the Company adjourned the Special Meeting. The reconvened Special Meeting will be held on Friday, September 19, 2025 at 8:30 a.m. Pacific Time through live webcast of the meeting, as described on the Proxy Statement and proxy card or in the instructions that accompanied the proxy materials to the Company's stockholders. During the period of the adjournment, the Company will continue to solicit votes from its stockholders with respect to the proposal for the Special Meeting. Stockholders who have already voted do not need to recast their votes. Proxies previously submitted in respect of the Special Meeting will be voted at the adjourned Special Meeting unless properly revoked in accordance with the procedures described in the Proxy Statement. The close of business on July 29, 2025 will continue to be the record date for the determination of stockholders of the Company entitled to vote at the Special Meeting.

Forward-Looking Statements

Forward-Looking Statements Additional Information and Where to Find It In connection with the Special Meeting of stockholders, the Company filed with the SEC a definitive Proxy Statement which was mailed to the Company's stockholders as of the record date for the Special Meeting of stockholders. STOCKHOLDERS AND OTHER INTERESTED PERSONS ARE ADVISED TO READ THE DEFINITIVE PROXY STATEMENT, AS WELL AS ALL AMENDMENTS AND SUPPLEMENTS THERETO, BECAUSE IT CONTAINS IMPORTANT INFORMATION ABOUT THE MATTERS BEFORE THE STOCKHOLDERS AT THE SPECIAL MEETING. The Company's stockholders may also obtain copies of the Proxy Statement and all other relevant documents filed or that will be filed with the SEC in connection with the Special Meeting, without charge, at the SEC's website at http://www.sec.gov or by directing a

01

Item 7.01 Regulation FD Disclosure. On September 8, 2025, the Company issued a press release announcing the adjournment of the Special Meeting. A copy of the press release is attached hereto as Exhibit 99.1. A previous version of the press release contained the incorrect website address for the live webcast for the Special Meeting, but the attached press release contains the corrected website address. The information in this Item 7.01, and Exhibit 99.1 attached hereto, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, regardless of any general incorporation language in such filing.

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits Exhibit Description 99.1 Press Release, dated September 8, 2025. 104 Cover Page Interactive Data File (embedded within Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 8, 2025 VAXART, INC. By: /s/ Steven Lo Steven Lo President and Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR